MC
GILD icon

Micawber Capital’s Gilead Sciences GILD Stock Holding History

Micawber Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.73M Sell
21,333
-4,923
-19% -$376K 2.75% 17
2017
Q2 		$1.86M Buy
26,256
+3,282
+14% +$218K 3.08% 16
2017
Q1 		$1.56M Buy
22,974
+3,759
+20% +$264K 2.57% 18
2016
Q4 		$1.38M Buy
+19,215
New +$1.43M 4.04% 13

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Micawber Capital's GILD Position: Q3 2017 in Review

Micawber Capital reduced its Gilead Sciences (GILD) stake by 19% in Q3 2017, selling an estimated $376K and leaving 21,333 shares worth $1.73M. The position accounts for 2.75% of the portfolio, ranked #17.

Micawber Capital first reported a position in GILD in Q4 2016 and has held it in 4 quarters since. The position peaked at $1.86M in Q2 2017. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Micawber Capital held 21,333 shares of Gilead Sciences worth $1.73M as of Q3 2017.
  • Micawber Capital sold 4,923 Gilead Sciences shares in Q3 2017, an estimated $376K.
  • Gilead Sciences made up 2.75% of Micawber Capital's portfolio in Q3 2017, its #17 holding.
  • Micawber Capital first reported a position in Gilead Sciences in Q4 2016 and has held it in 4 quarters since.
  • Micawber Capital's Gilead Sciences position peaked at $1.86M in Q2 2017.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Micawber Capital's 13F filing for Q3 2017, filed 3 Nov 2017.